Sector ratings Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2024-09-12 EDT			5-day change	1st Jan Change
914.20 ^DKK	+2.66%		+3.28%	+30.96%

11:36am	Eli Lilly invests $1.8 billion in Ireland sites to scale up Alzheimer's, obesity drug production	RE
10:40am	NOVO NORDISK : Deutsche Bank keeps its Buy rating	ZD

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	ESG Refinitiv	Capi. ($)
NOVO NORDISK A/S	B	583B
ELI LILLY AND COMPANY	C+	829B
JOHNSON & JOHNSON	C+	397B
ABBVIE INC.	C+	344B
MERCK & CO., INC.	B-	291B
ROCHE HOLDING AG	A+	255B
ASTRAZENECA PLC	B+	248B
NOVARTIS AG	B-	232B
AMGEN INC.	C+	177B
PFIZER, INC.	C+	168B
SANOFI	B+	144B
GILEAD SCIENCES, INC.	B-	101B
BRISTOL-MYERS SQUIBB COMPANY	B	98.51B
GSK PLC	B	87.89B
CHUGAI PHARMACEUTICAL CO., LTD	A-	75.39B
DAIICHI SANKYO CO., LTD.	A-	69.9B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	B+	47.01B
HALEON PLC	B	46.8B
JIANGSU HENGRUI MEDICINE CO., LTD.	B	40.57B
Average	B	222.92B
Weighted average by Cap.	B